Adaptilens is developing an accommodating intraocular lens (IOL) that adapts to the patient's surroundings, aiming to replicate the human lens as closely as possible.

Adaptilens

Adaptilens is the only IOL that imitates the human eye’s natural lens. We are a team of ophthalmologists, cataract specialists, scientists, and engineers with a singular focus on improving the vision and quality of life of cataract patients. We are developing an accommodating IOL with novel polymers to give patients the ability to focus not just on a single distance but on objects near, far, and in between--without the help of glasses or contact lenses. To stay updated as our life-changing lens technology develops, follow us here or sign up for updates here: https://adaptilens.com/contact/

MassChallenge

Pillar VC

Accanto Partners

MassChallenge, one of Adaptilens’s earliest supporters, connects with CEO Liane Clamen, MD for an update. Check out the article below! 

https://lnkd.in/gCB9PNyx

Adaptilens Founder and CEO, Liane Clamen, MD, was honored to lead a roundtable discussion at a Harvard Innovation Labs' forum last week.

This week, the Boston Business Journal featured Dr. Liane Clamen, CEO of Adaptilens, highlighting her remarkable accomplishments in developing a best-in-class intraocular lens.

Adaptilens Founder and CEO Dr. Liane Clamen was honored to be invited to give a presentation on Adaptilens at the International Society of Presbyopia conference in Vienna. Adaptilens’ game-changing Accommodating Intraocular Lens will improve the quality of life of millions of people. #IOL #Ophthalmolgy #innovation

Adaptilens is proud to announce our Series A Financing of $17.5M led by Perceptive Advisors (Perceptive Xontogeny Venture Funds) with participation by Pillar VC, 380 Cap, and Accanto Partners. Together we are transforming the standard of care for cataract surgery.
https://lnkd.in/e7h86cha

Adaptilens CEO, Dr. Liane Clamen, will be co-hosting the 2023 Founder-led Biotech Tour! RSVP below to join her and other inspirational founders in Boston on November 7.

Scientific Advisory Board Member

Cindy Chao

Founder and CEO

Liane Clamen

Chief Innovation & Technology Officer

Brett Thomes

Gianna Hoffman-Luca

Boston Companies (Top 10K)

Northeastern US Health Care Female Founded Companies with Early Stage Venture Funding

United States Health Care Female Founded Companies (Top 10K)

New England Female Founded Companies

Adaptilens is a developer of an accommodating intraocular lens. Adaptilen's mission is to bring to market an accommodative intraocular lens that mimics the natural human lens so that patients will have excellent near and distance vision without eyeglasses or contact lenses.

Perceptive Advisors

Series A - Adaptilens

Seed Round - Adaptilens

Non Equity Assistance - Adaptilens

Boston

Massachusetts

United States

North America

Adaptilens: $17.5 MIllion Raised For Transforming The Care For Cataract Surgery

ADAPTILENS ANNOUNCES $17.5M SERIES A FINANCING

Adaptilens Raises $17.5M in Series A Funding

Startup that aims to revolutionize cataract surgery raises $17.5M

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 18, 2024 5:24 AM	3ce4c665
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:51 PM	ae4a92e5
crunchbase profile	general	Oct 28, 2024 2:46 PM	828f3d23
li profile	general	Jul 18, 2024 5:24 AM	5c412b03
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	ecbf2e0c
peers	general	Jul 18, 2024 5:24 AM	d9d37f34
news basic	general	Jul 18, 2024 5:24 AM	d0f61118
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ADAPTILENS

Adaptilens